148 related articles for article (PubMed ID: 22731725)
21. Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease.
Wehkamp J; Schmid M; Fellermann K; Stange EF
J Leukoc Biol; 2005 Apr; 77(4):460-5. PubMed ID: 15618294
[TBL] [Abstract][Full Text] [Related]
22. Stress-induced barrier disruption of rat follicle-associated epithelium involves corticotropin-releasing hormone, acetylcholine, substance P, and mast cells.
Keita AV; Söderholm JD; Ericson AC
Neurogastroenterol Motil; 2010 Jul; 22(7):770-8, e221-2. PubMed ID: 20149111
[TBL] [Abstract][Full Text] [Related]
23. Abnormal intestinal permeability in Crohn's disease pathogenesis.
Teshima CW; Dieleman LA; Meddings JB
Ann N Y Acad Sci; 2012 Jul; 1258():159-65. PubMed ID: 22731729
[TBL] [Abstract][Full Text] [Related]
24. Polymorphisms in E-cadherin (CDH1) result in a mis-localised cytoplasmic protein that is associated with Crohn's disease.
Muise AM; Walters TD; Glowacka WK; Griffiths AM; Ngan BY; Lan H; Xu W; Silverberg MS; Rotin D
Gut; 2009 Aug; 58(8):1121-7. PubMed ID: 19398441
[TBL] [Abstract][Full Text] [Related]
25. Mucosal integrity and barrier function in the pathogenesis of early lesions in Crohn's disease.
Sanders DS
J Clin Pathol; 2005 Jun; 58(6):568-72. PubMed ID: 15917403
[TBL] [Abstract][Full Text] [Related]
26. NOD2 and defensins: translating innate to adaptive immunity in Crohn's disease.
Peyrin-Biroulet L; Chamaillard M
J Endotoxin Res; 2007; 13(3):135-9. PubMed ID: 17621555
[TBL] [Abstract][Full Text] [Related]
27. Pathogenic agents in inflammatory bowel diseases.
Pineton de Chambrun G; Colombel JF; Poulain D; Darfeuille-Michaud A
Curr Opin Gastroenterol; 2008 Jul; 24(4):440-7. PubMed ID: 18622157
[TBL] [Abstract][Full Text] [Related]
28. Dislocation of tight junction proteins without F-actin disruption in inactive Crohn's disease.
Oshitani N; Watanabe K; Nakamura S; Fujiwara Y; Higuchi K; Arakawa T
Int J Mol Med; 2005 Mar; 15(3):407-10. PubMed ID: 15702229
[TBL] [Abstract][Full Text] [Related]
29. Modulation of intestinal immune system by dietary fat intake: relevance to Crohn's disease.
Miura S; Tsuzuki Y; Hokari R; Ishii H
J Gastroenterol Hepatol; 1998 Dec; 13(12):1183-90. PubMed ID: 9918423
[TBL] [Abstract][Full Text] [Related]
30. Antagonism of Adherent Invasive E. coli LF82 With Human α-defensin 5 in the Follicle-associated Epithelium of Patients With Ileal Crohn's Disease.
Alkaissi LY; Winberg ME; Heil SDS; Haapaniemi S; Myrelid P; Stange EF; Söderholm JD; Keita ÅV
Inflamm Bowel Dis; 2021 Jun; 27(7):1116-1127. PubMed ID: 33336693
[TBL] [Abstract][Full Text] [Related]
31. Crohn's disease: the case for bacteria.
Prantera C; Scribano ML
Ital J Gastroenterol Hepatol; 1999 Apr; 31(3):244-6. PubMed ID: 10379488
[TBL] [Abstract][Full Text] [Related]
32. Translocation of enteropathogenic Escherichia coli across an in vitro M cell model is regulated by its type III secretion system.
Martinez-Argudo I; Sands C; Jepson MA
Cell Microbiol; 2007 Jun; 9(6):1538-46. PubMed ID: 17298392
[TBL] [Abstract][Full Text] [Related]
33. [The enteric glia--part of the puzzle in Crohn's disease?].
von Boyen G; Reinshagen M
Z Gastroenterol; 2011 Nov; 49(11):1482-6. PubMed ID: 22069048
[TBL] [Abstract][Full Text] [Related]
34. Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn's disease.
D'Incà R; Annese V; di Leo V; Latiano A; Quaino V; Abazia C; Vettorato MG; Sturniolo GC
Aliment Pharmacol Ther; 2006 May; 23(10):1455-61. PubMed ID: 16669960
[TBL] [Abstract][Full Text] [Related]
35. Intestinal epithelial barrier dysfunction in Crohn's disease.
Ma TY
Proc Soc Exp Biol Med; 1997 Apr; 214(4):318-27. PubMed ID: 9111522
[TBL] [Abstract][Full Text] [Related]
36. Peyer's patch lymphoid follicle epithelial adherence of a rabbit enteropathogenic Escherichia coli (strain RDEC-1). Role of plasmid-mediated pili in initial adherence.
Inman LR; Cantey JR
J Clin Invest; 1984 Jul; 74(1):90-5. PubMed ID: 6145724
[TBL] [Abstract][Full Text] [Related]
37. [Activation of the major omentum-associated lymphoid tissue in Crohn disease].
Schreiber S; Gehrckens A; Raedler A
Zentralbl Chir; 1995; 120(2):135-44. PubMed ID: 7709665
[TBL] [Abstract][Full Text] [Related]
38. Pathogenesis of aphthoid ulcers in Crohn's disease: correlative findings by magnifying colonoscopy, electron microscopy, and immunohistochemistry.
Fujimura Y; Kamoi R; Iida M
Gut; 1996 May; 38(5):724-32. PubMed ID: 8707119
[TBL] [Abstract][Full Text] [Related]
39. Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease.
Neut C; Bulois P; Desreumaux P; Membré JM; Lederman E; Gambiez L; Cortot A; Quandalle P; van Kruiningen H; Colombel JF
Am J Gastroenterol; 2002 Apr; 97(4):939-46. PubMed ID: 12003430
[TBL] [Abstract][Full Text] [Related]
40. High prevalence of aggregative adherent Escherichia coli strains in the mucosa-associated microbiota of patients with inflammatory bowel diseases.
Thomazini CM; Samegima DA; Rodrigues MA; Victoria CR; Rodrigues J
Int J Med Microbiol; 2011 Aug; 301(6):475-9. PubMed ID: 21616711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
